-
公开(公告)号:US20230133465A1
公开(公告)日:2023-05-04
申请号:US17673269
申请日:2022-02-16
申请人: Alzheon, Inc.
发明人: Petr Kocis , Martin Tolar , John Hey
IPC分类号: C07C309/26 , C07C309/19 , C07D207/14 , C07D207/16 , C07C317/50 , C07D401/06 , C07C323/59 , C07D403/12 , C07K5/00 , C07D233/26 , C07D403/06 , C07K5/078 , C07D401/12 , C07D209/20 , C07D295/185 , C07C323/60 , C07D211/58 , C07C309/27 , A61P25/28
摘要: Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.
-
公开(公告)号:US11053192B2
公开(公告)日:2021-07-06
申请号:US16807747
申请日:2020-03-03
申请人: Alzheon, Inc.
发明人: Petr Kocis , Martin Tolar , John Hey
IPC分类号: C07C309/26 , C07C309/19 , C07D207/14 , C07D207/16 , C07C317/50 , C07D401/06 , C07C323/59 , C07D403/12 , C07D233/26 , C07D403/06 , C07D401/12 , C07D209/20 , C07D295/185 , C07C323/60 , C07D211/58 , C07C309/27 , A61P25/28 , C07K5/00 , C07K5/078
摘要: Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.
-
公开(公告)号:US10315996B2
公开(公告)日:2019-06-11
申请号:US15579111
申请日:2016-06-03
申请人: LEAD PHARMA HOLDING B.V. , SANOFI
IPC分类号: C07C311/20 , C07C317/44 , C07C317/50 , C07D207/06 , C07D209/08 , C07D211/16 , C07D211/26 , C07D211/60 , C07D213/75 , C07D213/82 , C07D215/08 , C07D217/02 , C07D223/16 , C07D231/40 , C07D241/04 , C07D261/08 , C07D277/46 , C07D285/135 , C07D295/13 , C07D295/192 , C07D307/52 , C07D333/36 , C07D417/04 , C07D495/04
摘要: Compounds according to Formula I: or a pharmaceutically acceptable salt wherein: A1 is NR1 or CR1, with R1 herein; the cyclopropyl moiety with one or more methyl and one or more F; A2-A5 are N or CR2-CR5, with no more than two of the four positions A in A2-A5 can be simultaneously N; R2-R5 are described; R6 and R7 are independently H, F, methyl, ethyl, hydroxyl or methoxy or R6 and R7 together is carbonyl, all alkyl groups, if substituted with one or more F; R8 is H or C(1-6)alkyl; A9-A12 are N or CR9-CR12, with no more than two of the four positions A in A9-A12 can be simultaneously N; R9-R12 herein; R13 and R14 herein; or R13 and R14 fused forming a ring having 5 to 7 atoms by joining R13 being C(1-6)alkyl or C(2-6)alkenyl. The RORγ compounds can treat RORγ mediated diseases.
-
4.
公开(公告)号:US09795139B2
公开(公告)日:2017-10-24
申请号:US15092641
申请日:2016-04-07
申请人: Dow AgroSciences LLC
发明人: Joseph D. Eckelbarger , Daniel I. Knueppel , Ronald J. Heemstra , Ronald Ross, Jr. , Kyle A. Dekorver , Kaitlyn Gray , Peter Vednor , Timothy P. Martin , Ricky Hunter , David A. Demeter , Tony K. Trullinger , Erich Baum , Zoltan L. Benko , Nakyen Choy , Gary Crouse , John F. Daeuble, Sr. , Fangzheng Li , Jeff Nissen , Michelle Riener , Tom Sparks , Frank Wessels , Maurice Yap
IPC分类号: A01N53/00 , A01N43/90 , C07D207/273 , A01N43/82 , C07D307/33 , C07D277/36 , C07D263/26 , C07D261/12 , C07D333/48 , C07D307/52 , C07D277/30 , C07D213/56 , C07C237/22 , C07D333/60 , C07D233/80 , C07D487/04 , A01N43/707 , A01N43/653 , A01N43/60 , A01N43/40 , A01N41/10 , A01N37/34 , A01N37/22 , C07D253/07 , C07D241/20 , C07C317/14 , C07C233/65 , C07C233/63 , C07D209/49 , C07C381/10 , C07D205/04 , C07C237/42 , C07D207/10 , C07D207/452 , C07C255/29 , C07C255/57 , C07D285/06 , C07D295/32 , C07D305/08 , C07C255/46 , C07D213/75 , C07C255/60 , C07C259/10 , C07D213/81 , C07D213/84 , C07D309/14 , C07D213/89 , C07D215/227 , C07C271/28 , C07C271/66 , C07D215/38 , C07D231/12 , C07D331/04 , C07D231/56 , C07D333/36 , C07D233/36 , C07C311/08 , C07C311/46 , C07D235/30 , C07C317/28 , C07C317/40 , C07C317/50 , C07C323/41 , C07C323/42 , C07C323/59 , C07D249/08 , C07C331/12
CPC分类号: A01N53/00 , A01N37/22 , A01N37/34 , A01N41/10 , A01N43/40 , A01N43/60 , A01N43/653 , A01N43/707 , A01N43/82 , A01N43/90 , C07C233/63 , C07C233/65 , C07C237/22 , C07C237/42 , C07C255/29 , C07C255/46 , C07C255/57 , C07C255/60 , C07C259/10 , C07C271/28 , C07C271/66 , C07C311/08 , C07C311/46 , C07C317/14 , C07C317/28 , C07C317/40 , C07C317/50 , C07C323/41 , C07C323/42 , C07C323/59 , C07C331/12 , C07C381/10 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D205/04 , C07D207/10 , C07D207/273 , C07D207/452 , C07D209/49 , C07D213/56 , C07D213/75 , C07D213/81 , C07D213/84 , C07D213/89 , C07D215/227 , C07D215/38 , C07D231/12 , C07D231/56 , C07D233/36 , C07D233/80 , C07D235/30 , C07D241/20 , C07D249/08 , C07D253/07 , C07D261/12 , C07D263/26 , C07D277/30 , C07D277/36 , C07D285/06 , C07D295/32 , C07D305/08 , C07D307/33 , C07D307/52 , C07D309/14 , C07D331/04 , C07D333/36 , C07D333/48 , C07D333/60 , C07D487/04
摘要: This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (“Formula One”).
-
公开(公告)号:US09701622B2
公开(公告)日:2017-07-11
申请号:US15179751
申请日:2016-06-10
申请人: Achaogen, Inc.
发明人: Brian D. Patterson , Qing Lu , James Bradley Aggen , Paola Dozzo , Ramesh Annasaheb Kasar , Martin Sheringham Linsell , Timothy Robert Kane , Micah James Gliedt , Darin James Hildebrandt , Glenn A. McEnroe , Frederick Cohen
IPC分类号: C07D213/64 , C07D333/70 , C07D471/04 , C07D213/81 , C07C259/06 , C07D213/79 , C07C313/12 , C07C317/46 , C07C317/50 , C07C323/60 , C07C317/28 , C07C323/42 , C07C313/04
CPC分类号: C07C259/06 , C07C313/04 , C07C313/12 , C07C317/28 , C07C317/46 , C07C317/50 , C07C323/42 , C07C323/60 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07D213/64 , C07D213/79 , C07D213/81 , C07D333/70 , C07D471/04
摘要: Antibacterial compounds of formula (I) are provided: as well as stereoisomers and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.
-
公开(公告)号:US09403758B2
公开(公告)日:2016-08-02
申请号:US14537048
申请日:2014-11-10
申请人: Achaogen, Inc.
发明人: Brian D. Patterson , Qing Lu , James Bradley Aggen , Paola Dozzo , Ramesh Annasaheb Kasar , Martin Sheringham Linsell , Timothy Robert Kane , Micah James Gliedt , Darin James Hildebrandt , Glenn A. McEnroe , Frederick Cohen
IPC分类号: C07D213/81 , C07D213/64 , C07D333/70 , C07C259/06 , C07D213/79 , C07D471/04 , C07C313/12 , C07C317/46 , C07C317/50 , C07C323/60 , C07C317/28 , C07C323/42
CPC分类号: C07C259/06 , C07C313/04 , C07C313/12 , C07C317/28 , C07C317/46 , C07C317/50 , C07C323/42 , C07C323/60 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07D213/64 , C07D213/79 , C07D213/81 , C07D333/70 , C07D471/04
摘要: Antibacterial compounds of formula (I) are provided: as well as stereoisomers and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.
摘要翻译: 提供式(I)的抗菌化合物:及其立体异构体及其药学上可接受的盐; 包含这些化合物的药物组合物; 通过施用这些化合物治疗细菌感染的方法; 以及这些化合物的制备方法。
-
公开(公告)号:US09351948B2
公开(公告)日:2016-05-31
申请号:US14608503
申请日:2015-01-29
申请人: Allergan, Inc.
IPC分类号: A61K31/17 , A61K31/4045 , A61K31/417 , A61K31/197 , A61K31/216 , C07C275/30 , C07C317/42 , C07C323/44 , C07D209/20 , C07D233/64 , C07K5/062 , C07K5/078 , C07K5/072 , C07C317/50 , C07C323/60
CPC分类号: A61K31/417 , A61K31/17 , A61K31/197 , A61K31/198 , A61K31/216 , A61K31/4045 , C07C275/30 , C07C317/42 , C07C317/50 , C07C323/44 , C07C323/60 , C07D209/20 , C07D233/64 , C07K5/06017 , C07K5/06034 , C07K5/06052 , C07K5/0606 , C07K5/06113 , C07K5/06147 , C07K5/06156 , Y02A50/401
摘要: The present invention relates to novel amide derivatives of N-urea substituted amino acids, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.
-
公开(公告)号:US09266828B2
公开(公告)日:2016-02-23
申请号:US14385714
申请日:2013-03-14
发明人: Alex Strongin , Maurizio Pellecchia , Elisa Barile
IPC分类号: C07C279/04 , A61K31/155 , A61P35/00 , C07C317/50 , A61K38/00 , C07K5/09 , C07K5/062
CPC分类号: C07C317/50 , A61K38/00 , C07K5/06034 , C07K5/0817 , Y02A50/385 , Y02A50/387 , Y02A50/389 , Y02A50/469
摘要: Disclosed herein are Furin/PC inhibitors for inhibiting Furin and other Propprotein Convertases. Method of making the Furin/PC inhibitors, chemical and biological characterization of the Furin/PC inhibitors, and the use of the Furin/PC inhibitors to treat infectious diseases, cancers, and inflammatory/autoimmune disorders, are also disclosed.
摘要翻译: 本文公开了用于抑制弗林蛋白酶和其它丙型蛋白质转化酶的弗林蛋白/ PC抑制剂。 还公开了制备Furin / PC抑制剂的方法,Furin / PC抑制剂的化学和生物学表征,以及使用Furin / PC抑制剂治疗感染性疾病,癌症和炎性/自身免疫性疾病。
-
公开(公告)号:US20150202332A1
公开(公告)日:2015-07-23
申请号:US14161809
申请日:2014-01-23
IPC分类号: A61K51/04 , G01N33/60 , C07C317/50 , C07C237/12 , C07C237/36
CPC分类号: A61K51/0406 , C07B59/001 , C07C233/47 , C07C233/51 , C07C233/83 , C07C235/52 , C07C271/22 , C07C311/19
摘要: Imaging agents are described that comprise labeled substrates capable of being introduced into cells via the cystine/glutamate antiporter. The substrates may be used for imaging or detecting oxidative stress in cells by introducing the labeled agents into cells via the cystine/glutamate antiporter and subsequent detection.
-
公开(公告)号:US09085571B2
公开(公告)日:2015-07-21
申请号:US14322808
申请日:2014-07-02
发明人: Arun K. Ghosh
IPC分类号: A61K31/40 , A61K31/44 , C07D207/02 , C07D211/04 , C07D413/12 , C07C311/29 , C07D217/04 , C07D263/32 , C07D277/28 , C07D417/04 , C07C317/32 , C07C317/50 , C07D217/12 , C07D277/30
CPC分类号: C07D413/12 , C07C311/29 , C07C317/32 , C07C317/50 , C07C2601/14 , C07D217/04 , C07D217/12 , C07D263/32 , C07D277/28 , C07D277/30 , C07D417/04
摘要: Novel compounds and compositions for treating patients in need of relief from HIV, AIDS and AIDS-related diseases are described. Methods for treating HIV, AIDS, and AIDS-related diseases using the compounds described herein are also described.
摘要翻译: 描述了用于治疗需要缓解艾滋病毒,艾滋病和艾滋病相关疾病的患者的新型化合物和组合物。 还描述了使用本文所述的化合物治疗HIV,AIDS和AIDS相关疾病的方法。
-
-
-
-
-
-
-
-
-